Katakura Industries Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Katakura Industries Co Ltd with three other
companies in this sector in Japan:
Nippon Chemiphar Co., Ltd.
sales of 35.69 billion Japanese Yen [US$333.69 million]
of which 97%
was Pharmaceutical Business),
Fuso Pharmaceutical Industries Ltd
(46.78 billion Japanese Yen [US$437.41 million]
of which 100%
was Pharmaceutical Business), and
Aska Pharmaceutical Company Limited
(48.53 billion Japanese Yen [US$453.73 million]
of which 91%
was Pharmaceutical Products Business).
Katakura Industries Co Ltd reported sales of ¥46.19 billion (US$431.83 million)
December of 2017.
decrease of 1.6%
versus 2016, when the company's sales were ¥46.93 billion.
The sales level in 2017 was fairly close to the level five years ago: in 2012, Katakura Industries Co Ltd had sales
of ¥47.23 billion.